Clinical Trial Update: Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of choline alfoscerate on cognitive function in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)

Snippet

Sponsor: Yuhan Corporation | Conditions: Alzheimer's Disease | Phase 4 | Status: UNKNOWN